🇺🇸 FDA
Patent

US 12043660

10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use

granted A61PA61P31/18

Quick answer

US patent 12043660 (10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P31/18